glucose, (beta-d)-isomer has been researched along with apixaban in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Chintala, M; Feng, W; Graziano, MP; Li, Q; Shang, J; Wang, M; Wu, W; Wu, Y | 1 |
| Aspinall, SL; Au, A; Cunningham, FE; Fina, PM; Glassman, PA; Moore, VR; Zhao, X | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and apixaban
| Article | Year |
|---|---|
Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the Arterio-Venous shunt model of thrombosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Benzhydryl Compounds; Blood Coagulation; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Models, Animal; Factor Xa Inhibitors; Female; Glucosides; Hypoglycemic Agents; Platelet Aggregation; Pyrazoles; Pyridones; Rats; Rats, Zucker; Thrombophilia; Thrombosis | 2014 |
Reporting of adverse drug events in the Veterans Health Administration for patients whose treatment with empagliflozin or apixaban was discontinued.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Benzhydryl Compounds; Comorbidity; Female; Glucosides; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Sociobiology; Sodium-Glucose Transporter 2 Inhibitors; United States; United States Department of Veterans Affairs | 2020 |